Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CVM US Equity

Cel Sci CorpHealth Care · Biological Products, (No Diagnostic Substances) · CIK 725363 · FY ends Sep 30
$1.64
+0.05 (+3.14%)
USD · as of 2026-08-19 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-09-302025-12-29none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · Not applicable.

Item 9A · ICFR · CEL-SCI’s CEO and CFO/COO concluded that the Company’s internal control over financial reporting was not effective as of September 30, 2025 as a result of material weaknesses in CEL-SCI’s internal control over financial reporting as described below.

Item 9A · disclosure controls · Based on this evaluation, CEL-SCI’s CEO and CFO/COO concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2025 as a result of material weaknesses in CEL-SCI’s internal control over financial reporting as described below.

2024-09-302025-01-13none statednot extractedNOT effectivedisclosedEDGAR

Item 3 · Not applicable.

Item 9A · disclosure controls · Based on this evaluation, CEL-SCI’s CEO and CFO/COO concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2024 as a result of material weaknesses in CEL-SCI’s internal control over financial reporting as described below.

2023-09-302023-12-21none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · Not applicable.

Item 9A · ICFR · CEL-SCI's Chief Executive and Financial Officer concluded that as of such date, CEL-SCI's internal control over financial reporting was not effective.

Item 9A · disclosure controls · CEL-SCI’s Chief Executive and Principal Financial Officer has concluded that, due to the material weaknesses described below, CEL-SCI’s disclosure controls and procedures were not effective as of September 30, 2023.

2022-09-302022-12-27none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · Not applicable.

Item 9A · ICFR · CEL-SCI's Chief Executive and Financial Officer concluded that as of such date, CEL-SCI's internal controls over financial reporting were not effective.

Item 9A · disclosure controls · CEL-SCI’s Chief Executive and Principal Financial Officer has concluded that, due to the material weaknesses described below, CEL-SCI’s disclosure controls and procedures were not effective as of September 30, 2022.

2021-09-302021-12-21none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · Not applicable.

Item 9A · ICFR · CEL-SCI's Chief Executive and Financial Officer concluded that as of such date, CEL-SCI's internal controls over financial reporting were effective.

Item 9A · disclosure controls · CEL-SCI’s Chief Executive and Principal Financial Officer has concluded that CEL-SCI’s disclosure controls were effective as of September 30, 2021.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.